Literature DB >> 22727737

Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study.

A Dregan1, H Moller, T Murray-Thomas, M C Gulliford.   

Abstract

AIMS: The present study aimed to evaluate the validity of cancer diagnoses and death recording in a primary care database compared with cancer registry (CR) data in England.
METHODS: The eligible cohort comprised 42,556 participants, registered with English general practices in the General Practice Research Database (GPRD) that consented to CR linkage. CR and primary care records were compared for cancer diagnosis, date of cancer diagnosis and death. Read and ICD cancer code sets were reviewed and agreed by two authors.
RESULTS: There were 5216 (91% of CR total) cancer events diagnosed in both sources. There were 494 (9%) diagnosed in CR only and 213 (4%) that were diagnosed in GPRD only. The predictive value of a GPRD cancer diagnosis was 96% for lung cancer, 92% for urinary tract cancer, 96% for gastro-oesophageal cancer and 98% for colorectal cancer. 'False negative' primary care records were sometimes accounted for by registration end dates being shortly before cancer diagnosis dates. The date of cancer diagnosis was median 11 (interquartile range -6 to 30) days later in GPRD compared with CR. Death records were consistent for the two sources for 3337/3397 (99%) of cases.
CONCLUSION: Recording of cancer diagnosis and mortality in primary care electronic records is generally consistent with CR in England. Linkage studies must pay careful attention to selection of codes to define eligibility and timing of diagnoses in relation to beginning and end of record.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727737     DOI: 10.1016/j.canep.2012.05.013

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  55 in total

1.  Identifying and characterizing cancer survivors in the US primary care safety net.

Authors:  Megan Hoopes; Teresa Schmidt; Nathalie Huguet; Kerri Winters-Stone; Heather Angier; Miguel Marino; Jackilen Shannon; Jennifer DeVoe
Journal:  Cancer       Date:  2019-06-07       Impact factor: 6.860

2.  Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.

Authors:  Neil M Davies; Amy E Taylor; Gemma Mj Taylor; Taha Itani; Tim Jones; Richard M Martin; Marcus R Munafò; Frank Windmeijer; Kyla H Thomas
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

3.  Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records.

Authors:  Luke T A Mounce; Sarah Price; Jose M Valderas; William Hamilton
Journal:  Br J Cancer       Date:  2017-05-11       Impact factor: 7.640

4.  Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Tianxi Cai; Vivian S Gainer; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-17       Impact factor: 11.382

5.  Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Su-Chun Cheng; Tianxi Cai; Andrew Cagan; Vivian S Gainer; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-07       Impact factor: 11.382

6.  Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.

Authors:  N E Morden; J C Munson; J Smith; T A Mackenzie; S K Liu; A N A Tosteson
Journal:  Osteoporos Int       Date:  2014-10-28       Impact factor: 4.507

7.  Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.

Authors:  Parisa Karimi; Brenda M Birmann; Lesley A Anderson; Charlene M McShane; Shahinaz M Gadalla; Joshua N Sampson; Sam M Mbulaiteye
Journal:  Br J Haematol       Date:  2018-04-20       Impact factor: 6.998

8.  Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink.

Authors:  Zhiwei Liu; Rotana Alsaggaf; Katherine A McGlynn; Lesley A Anderson; Huei-Ting Tsai; Bin Zhu; Yue Zhu; Sam M Mbulaiteye; Shahinaz M Gadalla; Jill Koshiol
Journal:  Gut       Date:  2018-11-17       Impact factor: 23.059

9.  Detection of incident breast and colorectal cancer cases from an administrative healthcare database in Catalonia, Spain.

Authors:  J M Escribà; M Banqué; F Macià; J Gálvez; L Esteban; L Pareja; R Clèries; X Sanz; X Castells; J M Borrás; J Ribes
Journal:  Clin Transl Oncol       Date:  2019-10-04       Impact factor: 3.405

10.  The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study.

Authors:  Richeek Pradhan; Hui Yin; Oriana H Y Yu; Laurent Azoulay
Journal:  Drug Saf       Date:  2020-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.